Life Sciences Investors delivered a 40.59% NAV return in 2025, supported by innovation-focused biotechnology. Read the full ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor ...

If 2025 had a theme for the Charlotte region's life sciences ecosystem, it was this: years of planning finally meeting their moment. From landmark facility openings to record-breaking workforce ...

SFDA is supporting safer food systems, more effective health care regulation and a stronger environment for research ...

PHRMAG uses the World Health Expo in Dubai to spotlight the biopharmaceutical sector’s growing role in shaping the region’s health innovation agenda ...

Partnership will deliver executive programs and convene global investors, policymakers, and experts to strengthen the ...

Biotechnology has emerged as the fastest-growing segment, valued at $11.46 billion, led by fermentation-based industries, ...

Wednesday announced a strategic collaboration to advance executive education, thought leadership, and cross-sector engagement ...

In 1930, Sir C.V. Raman, one of India’s most eminent physicists was awarded the Nobel Prize in Physics for his outstanding discovery on the scattering of light, ...

The 2026 edition reinforces the Kingdom’s commitment to building a world class life sciences ecosystem that delivers national health, economic and innovation benefits ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript February 26, 2026 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.14 ...

Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in ...